Dr.
Dr Christine Muttiah
Oncology
- 🇬🇧
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Dr Christine Muttiah
Dr Christine Muttiah is a medical oncologist with a special interest in breast cancer. Their work and research focus on new, targeted therapies for hormone-positive breast cancer. Dr Muttiah is also interested in breast cancer prevention in patients with BRCA1/BRCA2 variants. Dr Muttiah is involved in clinical trials and research. They are an investigator in the first international phase 3 breast cancer prevention study, 'BRCA-P', and a phase 1 study, 'PALVEN', for advanced ER+ BCL-2+ breast cancer. Dr Muttiah has also completed a Master's Degree by research through the University of Melbourne, focusing on treating ER-positive breast cancer.
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) ·
#-866989
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Oncology
#EB-4E04DCE6
Renewal due 2033
Verify with issuerMalpractice cover
Generali Healthcare
5,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2012–2018
MD · Medicine and Surgery
Universitat de Barcelona
-
2018–2022
Residency · Oncology
Universitat de València
Career & appointments
-
2022-09–2023-08
Junior consultant
Universitat de Barcelona Teaching Hospital — Oncology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
309 |
| Annual physical exam | 99395 |
1,827 |
| Vaccination administration | 90471 |
2,107 |
| Minor procedure (skin) | 17110 |
876 |
Patient reviews
See all 468"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2023
- national college of family doctors — Member · since 2023
- European Union of Medical Specialists (UEMS) — Member · since 2023
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Research & publications
h-index: 17 · i10: 5
Selected publications
-
Long-term follow-up of Oncology across
DOI: 10.6612/euroclin.2026.0 · cited by 101
-
Validation of clinical scoring in Oncology
DOI: 10.3155/euroclin.2025.1 · cited by 71
-
Long-term follow-up of Oncology across
DOI: 10.5158/euroclin.2024.2 · cited by 153
Show full research record
Invited talks
- Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
- Single-centre experience in Oncology · National Society Meeting · · 2023
Articles by Dr Christine Muttiah
Frequently asked
01. Do you accept new patients?
Dr Christine Muttiah is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
Please use the booking flow to enter your insurance — we verify and confirm before your slot.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.
Book Dr Christine Muttiah
Similar Oncology specialists
Other verified specialists you may want to compare.